Have your own idea? Try our Stock Screener
UPDATED Nov 25, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LGND | US$124.33 | 3.1% | 114.3% | US$2.3b | US$140.25 | PE51.9x | E35.5% | n/a | ||
VRDN | US$21.91 | 4.2% | 39.9% | US$1.7b | US$40.63 | PS5746.9x | E31.6% | n/a | ||
NGNE | US$26.87 | 20.4% | n/a | US$330.9m | US$55.60 | PS430.8x | E-29.9% | n/a | ||
SPRY | US$14.37 | 4.8% | 198.4% | US$1.3b | US$26.50 | PS543.8x | E69.8% | n/a | ||
CRNX | US$56.77 | 1.2% | 81.1% | US$5.2b | US$73.29 | PS5067.1x | E9.0% | n/a | ||
RYTM | US$59.94 | 1.5% | 76.1% | US$3.7b | US$70.27 | PS32.7x | E66.7% | n/a | ||
KRYS | US$196.52 | 1.0% | 94.8% | US$5.6b | US$207.78 | PE107.9x | E41.2% | n/a | ||
IBRX | US$5.12 | 1.6% | 26.7% | US$3.5b | US$14.25 | PS486.6x | E72.9% | n/a | ||
CDNA | US$25.12 | 4.2% | 157.3% | US$1.3b | US$34.67 | PS4.3x | E95.0% | n/a | ||
TARS | US$49.66 | 2.8% | 199.3% | US$1.8b | US$65.33 | PS14.6x | E67.2% | n/a | ||
ALLO | US$2.52 | 10.5% | -2.3% | US$478.1m | US$9.04 | PS12287.8x | E4.7% | n/a | ||
NTLA | US$14.79 | 3.4% | -51.7% | US$1.5b | US$59.78 | PS35x | E26.4% | n/a | ||
RVTY | US$115.07 | 0.4% | 31.1% | US$14.0b | US$138.68 | PE54.2x | E19.9% | 0.2% | ||
NUVL | US$96.30 | 0.7% | 55.3% | US$6.8b | US$115.50 | PB6.1x | E4.5% | n/a | ||
SLNO | US$58.34 | 2.0% | 112.4% | US$2.5b | US$74.25 | PB9.5x | E67.3% | n/a | ||
BPMC | US$94.63 | 0.8% | 38.4% | US$6.0b | US$125.58 | PS13.8x | E68.6% | n/a | ||
COGT | US$9.63 | 4.7% | 36.5% | US$1.0b | US$16.36 | PB5.2x | E35.8% | n/a | ||
CATX | US$4.40 | 19.2% | 73.4% | US$249.4m | US$16.35 | PS191x | E-13.9% | n/a | ||
MRVI | US$5.62 | 6.2% | 9.8% | US$750.4m | US$9.73 | PS2.9x | E84.7% | n/a | ||
OLMA | US$9.72 | 9.1% | -28.3% | US$510.2m | US$27.86 | PB2.8x | E-4.1% | n/a | ||
BIO | US$337.73 | 0.5% | 10.9% | US$9.4b | US$402.33 | PS3.7x | E43.3% | n/a | ||
SEPN | US$24.28 | 4.4% | n/a | US$1.0b | US$43.67 | PS1099x | E-63.2% | n/a | ||
BCRX | US$7.49 | 3.0% | 39.0% | US$1.5b | US$14.64 | PS3.8x | E72.8% | n/a | ||
FOLD | US$9.87 | 1.5% | -6.7% | US$2.9b | US$17.75 | PS6x | E66.6% | n/a |